LIOF | Enterprise Europe Network

Health Innovation Euregion 2026

18 Jun 2026 | Netherlands

MosaMatrix BV

Company

www.mosamatrix.comOxfordlaan 55, 6229EV Maastricht, Netherlands
34 profile visits

About

MosaMatrix has developed a new class of hydrogel biomaterials for 3D cell-culturing. It is animal free, reproducable and fit in automated screening processes and comes with high cell survival and excellent tissue maturation. The hydrogel is easy to handle and it’s chemistry allows the addition of peptide fragments and the biomechanics properties can vary over a broad ranges of stiffness and elasticity.

LIFE SCIENCE

Diagnostics

VALUE CHAIN

Design / R&D / Engineering

MEDICINE

Diagnostics, DiagnosisMedical Technology / Biomedical EngineeringPharmaceutical Products / Drugs

Representatives

CEO

MosaMatrix BV